{"id":"NCT03911401","sponsor":"Otsuka Pharmaceutical Co., Ltd.","briefTitle":"Comparison Trial of OPA-15406 Ointment in Pediatric Patients With Atopic Dermatitis","officialTitle":"A Multicenter, Randomized, Double-blind, Vehicle Controlled, Parallel-group Comparison Trial to Demonstrate the Superiority of 0.3% and 1% OPA-15406 Ointment to the Vehicle in Pediatric Patients With Atopic Dermatitis (Phase 3 Trial)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-05-07","primaryCompletion":"2019-12-13","completion":"2019-12-13","firstPosted":"2019-04-11","resultsPosted":"2021-01-25","lastUpdate":"2021-01-25"},"enrollment":251,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Atopic Dermatitis"],"interventions":[{"type":"DRUG","name":"0.3% OPA-15406","otherNames":[]},{"type":"DRUG","name":"1% OPA-15406","otherNames":[]},{"type":"DRUG","name":"Placebos","otherNames":[]}],"arms":[{"label":"0.3% OPA-15406","type":"EXPERIMENTAL"},{"label":"1% OPA-15406","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"To demonstrate the superiority of the investigational medicinal product (IMP; 0.3% OPA-15406 ointment, 1% OPA-15406 ointment, or vehicle) to the vehicle when administered twice daily for 4 weeks using success rate in Investigator's Global Assessment (IGA) at Week 4 as the primary endpoint in pediatric patients with Atopic Dermatitis (AD).","primaryOutcome":{"measure":"Responder Rate of Investigator's Global Assesment (IGA) of Disease Severity","timeFrame":"At Week 4","effectByArm":[{"arm":"0.3% OPA-15406","deltaMin":44.58,"sd":null},{"arm":"1% OPA-15406","deltaMin":47.06,"sd":null},{"arm":"Placebo","deltaMin":18.07,"sd":null}],"pValues":[]},"eligibility":{"minAge":"2 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":1},"locations":{"siteCount":1,"countries":["Japan"]},"refs":{"pmids":["34289086"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":83},"commonTop":["Nasopharyngitis","Impetigo"]}}